Cargando…

Update on the use of trandolapril in the management of cardiovascular disorders

Trandolapril is a well known angiotensin converting enzyme (ACE) inhibitor with many cardiovascular (CV) indications. The objectives of this article are to review the pharmacokinetics and pharmacodynamics properties of trandolapril and to focus on its clinical relevance in cardiovascular medicine. V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diaz, Ariel, Ducharme, Anique
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663436/ https://www.ncbi.nlm.nih.gov/pubmed/19337528

Ejemplares similares

Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination
por: Sharma, Sanjib Kumar, et al.
Publicado: (2007)

Trandolapril/verapamil combination in hypertensive diabetic patients
por: García Donaire, José A, et al.
Publicado: (2007)

HPTLC METHOD DEVELOPMENT AND VALIDATION OF TRANDOLAPRIL IN BULK AND PHARMACEUTICAL DOSAGE FORMS
por: Sreekanth, N., et al.
Publicado: (2010)

Stability-Indicating HPLC Determination of Trandolapril in Bulk Drug and Pharmaceutical Dosage Forms
por: Al-Hawash, Leena A., et al.
Publicado: (2015)

Effects of Trandolapril on Structural, Contractile and Electrophysiological Remodeling in Experimental Volume Overload Heart Failure
por: Jarkovská, Dagmar, et al.
Publicado: (2021)

Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?
por: Jarjour, Marilyne, et al.
Publicado: (2023)

Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers
por: Wang, Xinwen, et al.
Publicado: (2021)

Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO)
por: Swedzky, Federico, et al.
Publicado: (2023)

Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial
por: Ruggenenti, Piero, et al.
Publicado: (2010)

Lessons learned from the pandemic that can be translated in the future
por: Ducharme, Anique
Publicado: (2022)

The treatment with trandolapril and losartan attenuates pressure and volume overload alternations of cardiac connexin-43 and extracellular matrix in Ren-2 transgenic rats
por: Sykora, Matus, et al.
Publicado: (2023)

Transition of CRT clinic to telemedicine during the COVID-19 pandemic: A missed opportunity to optimized patients with heart failure with reduced ejection fraction?()
por: Ducharme, Anique, et al.
Publicado: (2021)

Update on Management of Cardiovascular Diseases in Women
por: Lucà, Fabiana, et al.
Publicado: (2022)

Proposal for an Ambulatory Heart Failure Management Curriculum for Cardiology Residency Training Programs
por: Almufleh, Aws, et al.
Publicado: (2022)

The use of sibutramine in the management of obesity and related disorders: An update
por: Tziomalos, Konstantinos, et al.
Publicado: (2009)

A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study
por: Atalar, Enver, et al.
Publicado: (2020)

Update on the Pathophysiology and Management of Anorectal Disorders
por: Patcharatrakul, Tanisa, et al.
Publicado: (2018)

Sleep Disorders in Stroke: An Update on Management
por: Cai, Hongxia, et al.
Publicado: (2021)

Management of acute intradialytic cardiovascular complications: Updated overview (Review)
por: Timofte, Delia, et al.
Publicado: (2021)

Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy
por: Denardo, Scott J., et al.
Publicado: (2015)

Severe myocarditis after SARS-CoV-2 vaccination in a 49-year-old woman
por: Olmos, Carla Vallejos, et al.
Publicado: (2022)

Cas grave de myocardite après vaccination anti-SRAS-CoV-2 chez une femme de 49 ans
por: Olmos, Carla Vallejos, et al.
Publicado: (2022)

Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy
por: Denardo, Scott J., et al.
Publicado: (2016)

Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction
por: Okpechi, Ikechi G, et al.
Publicado: (2010)

Neuro-stimulation Techniques for the Management of Anxiety Disorders: An Update
por: Kar, Sujita Kumar, et al.
Publicado: (2016)

Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β‐Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil‐SR Trandolapril Study) Trials
por: Magvanjav, Oyunbileg, et al.
Publicado: (2017)

Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
por: Asselin, Caroline, et al.
Publicado: (2013)

Updated Perspectives on the Management of Sleep Disorders in the Intensive Care Unit
por: Nilius, Georg, et al.
Publicado: (2021)

Assessment and management of cardiovascular complications in eating disorders
por: Friars, Dara, et al.
Publicado: (2023)

Learning SPARQL: querying and updating with SPARQL 1.1
por: DuCharme, Bob
Publicado: (2013)

Borderline personality disorder and substance use disorders: an updated review
por: Trull, Timothy J., et al.
Publicado: (2018)

An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders
por: Lamanna-Rama, Nicolás, et al.
Publicado: (2022)

Updates on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2017)

Vitamin C and Cardiovascular Disease: An Update
por: Morelli, Marco B., et al.
Publicado: (2020)

Targeting Cardiovascular Diseases by Flavonols: An Update
por: Kozłowska, Aleksandra, et al.
Publicado: (2022)

Updated Review on the Diagnosis and Primary Management of Psychogenic Nonepileptic Seizure Disorders
por: Lanzillotti, Alejandra Inés, et al.
Publicado: (2021)

Latest Concepts in the Endodontic Management of Patients with Cardiovascular Disorders
por: Kuzekanani, Maryam, et al.
Publicado: (2019)

Updated Perspectives on the Neurobiology of Substance Use Disorders Using Neuroimaging
por: Murnane, Kevin S, et al.
Publicado: (2023)

Update on optimal use of omalizumab in management of asthma
por: Pelaia, Girolamo, et al.
Publicado: (2011)

Update on the use of deferasirox in the management of iron overload
por: Taher, Ali, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jgnghakuai63s1d0660vep0rpj